kabutan

MEDINET Co., Ltd.(2370) Summary

2370
TSE Growth
MEDINET Co., Ltd.
30
JPY
-1
(-3.23%)
Mar 13, 3:30 pm JST
0.18
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
30.4
Mar 13, 11:25 pm JST
Summary Chart Historical News Financial Result
PER
PBR
2.34
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
30 JPY 0.18 USD
Previous Close Mar 12
31 JPY 0.19 USD
High Mar 13, 9:04 am
31 JPY 0.19 USD
Low Mar 13, 9:00 am
30 JPY 0.18 USD
Volume
688,100
Trading Value
0.02B JPY 0.13M USD
VWAP
30.02 JPY 0.19 USD
Minimum Trading Value
3,000 JPY 18 USD
Market Cap
8.00B JPY 0.05B USD
Number of Trades
49
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
172
1-Year High Jun 24, 2025
1,875
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 12,279,200
Feb 27, 2026 0 12,763,200
Feb 20, 2026 40,000 12,587,500 314.69
Feb 13, 2026 0 11,086,300
Feb 6, 2026 0 11,335,100
Company Profile
MEDINET Co., Ltd. is a venture business originating from the Institute of Medical Science at the University of Tokyo. The company provides comprehensive services for cancer immunotherapy and is also involved in pharmaceutical development.
Sector
Services
MEDINET Co., Ltd. operates in the cell processing industry and regenerative medicine product business. In the cell processing industry, the company manufactures specific cell products for medical institutions, contracts the production of clinical and trial cell products for companies and universities, manages cell culture processing facilities, and provides dispatch and education systems for cell processing technicians. In the regenerative medicine product business, MEDINET Co., Ltd. aims to obtain manufacturing and marketing approval for regenerative medicine products through joint research with universities and other institutions.